NCT02284438

Brief Summary

Three endotracheal tubes (ETTs) with different surfaces properties will be studied regarding formation and structure of the biofilm formed on those ETTs. Cultures from oropharynx and tracheal secretions as well as pieces of the ETT will be examined. Findings from electron microscopy (EM) and microbiology will be analyzed and compared in respect to the three materials.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
102

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2014

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

October 21, 2014

Completed
16 days until next milestone

First Posted

Study publicly available on registry

November 6, 2014

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2017

Completed
2.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2020

Completed
Last Updated

April 28, 2020

Status Verified

December 1, 2018

Enrollment Period

3.6 years

First QC Date

October 21, 2014

Last Update Submit

April 27, 2020

Conditions

Keywords

ETTBiofilmMechanical ventilationCritical illnessVentilator-associated pneumonia

Outcome Measures

Primary Outcomes (1)

  • Structure, thickness, and presence of microbes of biofilm developed on endotracheal tube

    Pieces of the tubes examined with electron microscopy and assessed for microbes

    After finished mechanical ventilation and extubation; expected average time on mechanical ventilation 5 days

Secondary Outcomes (4)

  • White Blood Cell count

    From admission to extubation. Expected average 5 days

  • C reactive protein

    From admission to extubation. Expected average 5 days

  • Length of stay, ICU and Hospital

    Three months from study inclusion

  • Survival

    Three months from study inclusion

Study Arms (1)

Biofilm formation on ETT

OTHER

Three different endotracheal tubes uses on intubated mechanical ventilated patients will after extubation be examined regarding biofilm, structure and presence of microbes on the ETTs The different tubes will be used during consecutive time periods The study does not include any interventions concerning the treatment of these critically ill patients

Device: Endotracheal tube

Interventions

Three endotracheal tubes with different surfaces will be used

Biofilm formation on ETT

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients needing invasive mechanical ventilation through an endotracheal tube

You may not qualify if:

  • Anticipated need for mechanical ventilation less than 24 hours

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Intensive Care Unit, Lund University Hospital

Lund, SE 221 85, Sweden

Location

Related Publications (2)

  • Gil-Perotin S, Ramirez P, Marti V, Sahuquillo JM, Gonzalez E, Calleja I, Menendez R, Bonastre J. Implications of endotracheal tube biofilm in ventilator-associated pneumonia response: a state of concept. Crit Care. 2012 May 23;16(3):R93. doi: 10.1186/cc11357.

    PMID: 22621676BACKGROUND
  • Thorarinsdottir HR, Kander T, Holmberg A, Petronis S, Klarin B. Biofilm formation on three different endotracheal tubes: a prospective clinical trial. Crit Care. 2020 Jun 29;24(1):382. doi: 10.1186/s13054-020-03092-1.

Related Links

MeSH Terms

Conditions

Respiratory InsufficiencyPneumonia, Ventilator-AssociatedCritical Illness

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesHealthcare-Associated PneumoniaCross InfectionInfectionsPneumoniaRespiratory Tract InfectionsLung DiseasesIatrogenic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Bengt Klarin, MD, PhD

    Dept Anaesthesiology and Intensive care, Skåne University Hospital, Lund Sweden

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD Consultant

Study Record Dates

First Submitted

October 21, 2014

First Posted

November 6, 2014

Study Start

April 1, 2014

Primary Completion

November 1, 2017

Study Completion

February 1, 2020

Last Updated

April 28, 2020

Record last verified: 2018-12

Data Sharing

IPD Sharing
Will share

Results will be published as an article in a scientific journal

Locations